Company Overview

McKesson Corporation is a global healthcare services and information technology company operating primarily in the pharmaceutical distribution, medical-surgical supply, and healthcare technology industries. The company’s core function is the distribution of prescription and over-the-counter pharmaceuticals, specialty drugs, and medical supplies to healthcare providers, pharmacies, manufacturers, and government entities. McKesson is one of the largest pharmaceutical distributors in the United States by revenue, serving a critical role in the healthcare supply chain.

McKesson’s primary revenue drivers include its U.S. Pharmaceutical distribution business, Prescription Technology Solutions, and Medical-Surgical Solutions operations. Its customer base spans retail pharmacies, hospital systems, physician offices, specialty clinics, and biopharmaceutical manufacturers. The company’s scale, logistics infrastructure, and technology-enabled services provide a strategic advantage in efficiency, regulatory compliance, and supply reliability. Founded in 1833 as a wholesale drug business, McKesson has evolved over nearly two centuries through organic growth, acquisitions, and divestitures into a diversified healthcare services leader.

Business Operations

McKesson operates through several major business segments, most notably U.S. Pharmaceutical, Prescription Technology Solutions, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment generates the majority of company revenue by distributing branded, generic, specialty, and biosimilar drugs, along with providing inventory management, reimbursement support, and data analytics services. Prescription Technology Solutions focuses on pharmacy management software, electronic prior authorization, and patient access tools, while Medical-Surgical Solutions distributes medical supplies and provides logistics and clinical supply chain services to healthcare providers.

Operations are primarily concentrated in the United States, with additional international activities through select subsidiaries and investments. McKesson controls extensive logistics assets, including automated distribution centers and technology platforms that support ordering, compliance, and data exchange. Key subsidiaries include McKesson Medical-Surgical Inc., CoverMyMeds, and RxCrossroads, and the company maintains long-term partnerships with pharmaceutical manufacturers, health systems, and retail pharmacy chains.

Strategic Position & Investments

McKesson’s strategy emphasizes disciplined capital allocation, operational efficiency, and expansion of higher-margin, technology-enabled healthcare services. Growth initiatives include scaling specialty drug distribution, expanding patient access and affordability solutions, and investing in data-driven healthcare platforms. The company has consistently streamlined its portfolio, exiting non-core international businesses while reinvesting in U.S.-focused pharmaceutical and healthcare technology operations.

Notable strategic actions include acquisitions that strengthened specialty distribution and patient support capabilities, as well as continued investment in CoverMyMeds and oncology-focused services through RxCrossroads. McKesson is also involved in emerging areas such as biosimilars distribution, real-world evidence analytics, and automation within pharmaceutical supply chains. Where disclosures differ on the long-term revenue contribution of certain technology investments, data is inconclusive based on available public sources.

Geographic Footprint

McKesson is headquartered in Irving, Texas, and its operational footprint is predominantly within North America, particularly the United States, where it serves all major regions through a nationwide distribution network. The company’s logistics infrastructure supports urban, suburban, and rural healthcare providers, giving it broad domestic market penetration.

Internationally, McKesson maintains a limited but strategic presence following the divestiture of several non-U.S. businesses in recent years. Remaining international exposure primarily consists of targeted investments, technology platforms, and partnerships rather than large-scale distribution operations. As a result, McKesson’s geographic influence is strongest in the U.S., with selective international reach supporting its core healthcare services strategy.

Leadership & Governance

McKesson is led by an experienced executive team with deep backgrounds in healthcare, logistics, and technology. The leadership emphasizes ethical governance, regulatory compliance, and long-term value creation, with a strategic vision centered on improving healthcare access, affordability, and outcomes through scale and innovation.

Key executives include:

• Brian S. Tyler – Chief Executive Officer
• Britt Vitalone – Executive Vice President and Chief Financial Officer
• Rebecca Morgan – Executive Vice President and Chief Operating Officer
• Narong Leelahaphan – Executive Vice President, U.S. Pharmaceutical
• Kristin Williams – Executive Vice President and Chief Information Officer

The Board of Directors provides oversight with a focus on corporate governance, risk management, and alignment with shareholder interests, consistent with standards outlined in SEC filings such as the Form 10-K and proxy statements.